We are proud to share that Altheome will be participating in the ImmunoMark Summit 2026, taking place on 5-6 March 2026 in London, UK. This key international meeting brings together leaders in immunology, biomarkers, and companion diagnostics to shape the future of precision medicine.

Our Founder & CEO, Adam Shellard, will be an expert speaker in the Biomarker and Companion Diagnostics track, where he will present Altheome’s latest insights into how cutting-edge biomarker strategies can transform drug development and patient care.

We look forward to engaging with researchers, biotech and pharma partners, and fellow innovators at the summit. If you’re attending, we’d be delighted to connect with you in London.